Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs. Pandey JP. Proc Natl Acad Sci U S A 2023;120:e2306078120.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pandey JP. Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs. Proc Natl Acad Sci U S A 2023;120:e2306078120.
PMID: 37216539